https://scholars.lib.ntu.edu.tw/handle/123456789/544065
標題: | Optimal C2 Concentration of Cyclosporin Corrected With Good Efficacy and Safety in Asian Kidney Transplant Recipients | 作者: | SHUO-MENG WANG Lai M.K. SHIH-CHIEH CHUEH Tai H.C. Chung S.D. |
公開日期: | 2008 | 卷: | 40 | 期: | 7 | 起(迄)頁: | 2243-2244 | 來源出版物: | Transplantation Proceedings | 摘要: | Introduction: Calcineurin inhibitors (CNI) are known for their renal toxicity. Lower CNI exposure is a reasonable option to mitigate potential CNI-induced renal toxicity. Herein we have presented our long-term results after lower cyclosporine (CsA) exposure in the first year. Materials and Methods: Between 1997 and 2004, 63 renal transplant recipients received CsA-based immunosuppression. CsA dosing was adjusted according to the 2-hour whole blood concentration (C2) level. We retrospectively reviewed acute rejection and graft survivals rates, as well as whole blood C2 levels. Results: Review of serial mean C2 concentrations at 1, 2, 3, 6, and 12 months after transplantation were 1341, 1241, 1191, 1059, and 927 ng/mL, respectively. These levels were slightly lower than those suggested by the Consensus for C2 levels by Levy et al in 2002, namely, 1600 to 2000 ng/mL (mean, 1700); 1400 to 1600 ng/mL (mean, 1500); 1200 to 1400 ng/mL (mean, 1300); 1000 to 1200 ng/mL (mean, 1100), and 800 to 1000 ng/mL (mean, 900), respectively. Acute rejection rate at 3 months and 1 year are 17.5% and 23.8%. Graft survival at 1 year was 97% and at 5 years, 89%. Two patient were lost to fulminant hepatitis and acute myocardial infarction during the first year, which were not associated with underimmunosuppression. Conclusion: Appropriate CsA C2 levels may be lower among Taiwanese. Our C2 dosing strategy resulted in good outcomes with acceptable side effects in our single-center experience. Appropriate CsA C2 levels for Asians deserve more attention in trials of larger scale; most reference levels are presently concluded from studies of Caucasians. ? 2008 Elsevier Inc. All rights reserved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-51449108638&doi=10.1016%2fj.transproceed.2008.06.030&partnerID=40&md5=54bd9fc9fbf67a8a5a70897d139393f8 https://scholars.lib.ntu.edu.tw/handle/123456789/544065 |
ISSN: | 0041-1345 | DOI: | 10.1016/j.transproceed.2008.06.030 | SDG/關鍵字: | azathioprine; cyclosporin A; mycophenolic acid 2 morpholinoethyl ester; steroid; corticosteroid; cyclosporin; drug derivative; immunosuppressive agent; mycophenolic acid; mycophenolic acid 2 morpholinoethyl ester; adult; article; Asian; controlled study; disease association; drug blood level; drug efficacy; drug safety; female; graft recipient; graft rejection; graft survival; heart infarction; hepatitis; human; human tissue; immunosuppressive treatment; kidney transplantation; major clinical study; male; priority journal; blood; follow up; immunology; middle aged; retrospective study; safety; time; Adrenal Cortex Hormones; Adult; Asian Continental Ancestry Group; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Safety; Time Factors |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。